MedTrace Logo

Comparison Between IT Fentanyl and IV Granisetron in Prevention of Vomiting in CS Under Spinal Anesthesia

NCT05474001 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-04-18

No results posted yet for this study

Summary

Intrathecal Fentanyl Versus Intravenous Granisetron for the Prevention of Perioperative Nausea and Vomiting During Cesarean Delivery under Spinal Anesthesia

Conditions

  • Nausea and Vomiting, Postoperative

Interventions

DRUG

Fentanyl

10mg bubivacain intrathecal ( 2ml ) with 20microgram intrathecal fentanyl

DRUG

Bupivacain

10mg bubivacain intrathecal (2ml) with 0.5 ml saline with no intrathecal fentanyl

DRUG

intravenous graniseton

10mg bubivacain intrathecal ( 2ml ) with 0.5 ml saline with no intrathecal fentanyl with 1mg iv granisetron

Sponsors & Collaborators

  • Mohamed Youssef Mohamed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-08-30
Completion
2024-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05474001 on ClinicalTrials.gov